Source: MarketScreener

CHEMI: Cadila Healthcare : Zydus partners with CHEMI of Italy to launch Enoxaparin Sodium Injection in the United State

(marketscreener.com) Zydus partners with CHEMI of Italy to launch Enoxaparin Sodium Injection in the United States Ahmedabad, 20th August, 2021 Zydus Pharmaceuticals Inc, USA , a leading innovation-driven, global healthcare provider, has signed a license and supply agreement with CHEMI...https://www.marketscreener.com/quote/stock/CADILA-HEALTHCARE-LIMITED-34067618/news/Cadila-Healthcare-Zydus-partners-with-CHEMI-of-Italy-to-launch-Enoxaparin-Sodium-Injection-in-the-36209147/?utm_medium=RSS&utm_content=20210820

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
250-500
Dario Giusti's photo - CEO of CHEMI

CEO

Dario Giusti

CEO Approval Rating

90/100



CHEMI is a Private company. CHEMI generates $317.8K in revenue per employee CHEMI has 1 followers on Owler.